Johns Hopkins Anti-Tumoral Immune Microenvironment Patent EP3787643A1

The EPO published patent application EP3787643A1 for The Johns Hopkins University relating to compositions and methods for inducing anti-tumoral immune microenvironments. The application designates all EU member states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR. Inventors are Elisseeff, Jennifer H. and Wolf, Matthew T. IPC classifications include A61K 35/13, A61K 35/22, A61L 15/22, A61L 27/36, C07K 16/28, A61L 27/54, and A61P 35/00.

For parties interested in immunotherapy research, cancer therapeutics development, or related licensing opportunities, this patent establishes intellectual property rights in the EU for Johns Hopkins University's technology platform. The designated states cover the major European pharmaceutical markets, making this significant for entities pursuing similar research or seeking cross-licensing arrangements in the oncology space.